Efficacy of Combined Modality Prophylaxis Including Short-Duration Warfarin to Prevent Venous Thromboembolism After Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 21, Issue 4, 2006, Pages 469-475

  Keeney, James A ^a   Clohisy, John C ^a   Curry, Madelyn C ^a   Maloney, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anticoagulation; Coumadin; deep vein thromboembolism; pulmonary embolism; total hip arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; WARFARIN;

ABSENCE OF SIDE EFFECTS; ANAMNESIS; ARTICLE; BLEEDING; CLINICAL TRIAL; ECHOGRAPHY; HIP ARTHROPLASTY; HUMAN; INCIDENCE; LEG; PROTECTIVE CLOTHING; RETROSPECTIVE STUDY; RISK FACTOR; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BANDAGES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS; WALKING; WARFARIN;

EID: 33744979737     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2005.06.017     Document Type: Article

References (32)

1. Coventry M.B., Nolan D.R., and Beckenbaugh R.D. Delayed prophylactic anticoagulation: a study of results and complications in 2,012 hip arthroplasties. J Bone Joint Surg 55A (1973) 1487
2. Miric A., Lombardi P., and Sculco T. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Am J Orthop 29 (2000) 269
3. Clagett G.P., Anderson Jr. F.A., Heit J., et al. Prevention of venous thromboembolism. Chest 108 Suppl (1995) 312S
4. Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: prevention of venous and pulmonary thromboembolism. JAMA 256 (1986) 744
5. Colwell Jr. C.W., Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge. J Bone Joint Surg 81A (1999) 932
6. Douketis J.D., Eikelboom J.W., Quinlan D.J., et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 162 (2002) 1465
7. Hooker J.A., Lachiewicz P.F., and Kelley S.S. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg 81A (1999) 690
8. Kearon C. Duration of venous thromboembolism after surgery. Chest 124 6 Suppl (2003) 386
9. Menzin J., Colditz G.A., Regan M.M., et al. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery. Arch Intern Med 155 (1995) 757
10. Anderson Jr. F.A., Hirsh J., White K., et al. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 124 6 Suppl (2003) 349
11. Mesko J.W., Brand R.A., Iorio R., et al. Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients: a survey of the AAHKS membership. J Arthroplasty 16 (2001) 679
12. Bern M.M., Bierbaum B., Wetzner S., et al. Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement. Am J Hematol 71 (2002) 69
13. Beuhler K.O., D'Lima D.D., Colwell Jr. C.W., et al. Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening. Clin Orthop 361 (1999) 168
14. Botteman M.F., Caprini J., Stephens J.M., et al. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther 24 (2002) 1960
15. Caprini J.A., Arcelus J.I., Motykie G., et al. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg 30 (1999) 813
16. Lieberman J.R., Wollaeger J., Dorey F., et al. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg 79A (1997) 319
17. Paiement G.D., Wessinger S.J., Hughes R., et al. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement. J Bone Joint Surg 75A (1993) 893
18. Prandoni P., Bruchi O., Sabbion P., et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 162 (2002) 1966
19. Samama C.M., Vray M., Barre J., et al. Arch Intern Med 162 (2002) 2191
20. Schmidt B., Michler R., Klein M., et al. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial. Thromb Haemost 90 (2003) 949
21. Turpie A.G., Bauer K.A., Eriksson B.I., et al. Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162 (2002) 1833
22. Turpie A.G., Eriksson B.I., Bauer K.A., et al. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest 124 6 Suppl (2003) 371
23. Agnelli G., Mancini G.B., and Biagini D. The rationale for long-term prophylaxis of venous thromboembolism. Orthopedics 23 Suppl (2000) 643
24. Bressollette L., Nonent M., Oger E., et al. Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients. Thromb Haemost 86 (2001) 529
25. Hull R.D., and Pineo G.F. Extended prophylaxis against venous thromboembolism following total hip and knee replacement. Haemostasis 29 Suppl (1999) 23
26. Anderson D.R., Gross M., Sobinson K.S., et al. Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications-the postarthroplasty screening study (PASS). Chest 114 Suppl (1998) 119
27. Anderson D.R., Wilson S.J., Blundell J., et al. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty. J Bone Joint Surg 84A (2002) 1992
28. Verlato F., Bruchi O., Prandoni P., et al. The value of ultrasonographic screening for proximal vein thrombosis after total hip arthroplasty-a prospective cohort study. Thromb Haemost 86 (2001) 534
29. Elias A., Cadene A., Elias M., et al. Extended lower limb venous ultrasound for the diagnosis of proximal and distal vein thrombosis in asymptomatic patients after total hip replacement. Eur J Vasc Endovasc Surg 27 (2004) 438
30. Grady-Benson J.C., Oishi C.S., Hanson P.B., et al. Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties. Clin Orthop 307 (1994) 130
31. Ciccone W.J., Fox P.S., and Neumeyer M. Ultrasound surveillance for asymptomatic deep venous thrombosis after total joint replacement. J Bone Joint Surg 80A (1998) 1167
32. Ryan M.G., Westrich G.H., Potter H.G., et al. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg 84A (2002) 1998